Excrement nucleic acid extraction kit and extraction method

Through the grinding of the fecal nucleic acid extraction kit and the use of specific formula decomposition liquids, the fecal nucleic acid extraction process is simplified, the problems of complex operation and low extraction efficiency are solved, and high-quality, safe and efficient nucleic acid extraction effect is achieved.

CN119061001APending Publication Date: 2024-12-03CHONGQING PUJI LIFE TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411135400.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing fecal nucleic acid extraction method is complex in operation and requires multiple steps and professional skills. The product is expensive or uses toxic chemicals, and the extraction efficiency is low, resulting in low nucleic acid quality, affecting the reliability of experimental results, and is not suitable for general laboratory personnel. use.

Method used

Provide a fecal nucleic acid extraction kit, including grinding beads, decomposition solution, lysate, magnetic bead suspension, washing solution and eluent, destroying cell walls through grinding, and removing phenols and acids in combination with specific formula decomposition solution. and polysaccharides, nucleic acid extraction is performed using magnetic bead suspension and surfactant, simplifying the operation process and improving extraction efficiency and purity.

Benefits of technology

It achieves high-quality, simple operation, safe and efficient fecal nucleic acid extraction, reduces the risk of pollution, is suitable for a wide range of laboratories, and improves the integrity and purity of nucleic acids.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061001A_ABST
    Figure CN119061001A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of fecal nucleic acid extraction, and particularly relates to a fecal nucleic acid extraction kit and method, the fecal nucleic acid extraction kit comprises grinding beads, an impurity removal solution, a lysis solution, a binding solution, a magnetic bead suspension, a washing solution and an eluent, the impurity removal solution comprises Al2 (SO4) 3 with the mass concentration of 5%-10%, Na4P2O7 with the mass concentration of 2%-8% and an alkaline solution of C4H10O with the mass concentration of 0.5%-2%, the excrement nucleic acid extraction method comprises the following steps: taking an excrement sample, adding a lysis solution and grinding beads, uniformly mixing at a full speed, homogenizing, breaking cell walls, heating, splitting, centrifuging, and sucking a supernatant A; adding an impurity removal solution into the supernate A, incubating and centrifuging to obtain supernate B, adding a magnetic bead suspension and a binding solution into the supernate B to form a magnetic bead-DNA compound, washing with a washing solution 1 and a washing solution 2, and eluting with an eluent to obtain excrement DNA. The kit disclosed by the invention can obtain a high-purity DNA sample, and is simple, convenient, safe and efficient; wide application prospects are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of feces nucleic acid extraction, and particularly relates to a feces nucleic acid extraction kit and an extraction method. Background Art

[0002] Fecal samples account for half of intestinal microbial samples. Compared with other sample types, the acquisition of fecal samples is non-invasive, and the microorganisms in feces can provide useful information for insight into metabolic status, health / disease status of humans / animals, and symbiosis with intestinal flora. At the same time, studies have shown that fecal samples contain a large number of exfoliated cells and free nucleic acids in the digestive tract. The detection of exfoliated cells and free nucleic acids can be used to understand the physiological changes of organs such as the gastrointestinal tract. With the development of molecular biology research and technology, many breakthroughs have been made in the use of molecular biology techniques and methods to extract DNA from feces and study related gastrointestinal diseases. In the US treatment guidelines, fecal genetic testing has been recommended as a means of colorectal cancer screening for people at risk.

[0003] The components contained in feces are very complex. Fecal samples contain a large number of microorganisms such as bacteria, fungi, viruses, and a large number of impurities. When extracting nucleic acids, it is necessary to overcome the influence of these interferences on the extraction efficiency. Substances such as pigments, polysaccharides and cellulose contained in feces have an inhibitory effect on TaqDNA polymerase, which will interfere with the amplification and detection of nucleic acids. The extracted nucleic acids need to be purified and possible inhibitors removed. Organic substances such as lipids, acids, and polyphenols are difficult to remove during the DNA extraction process. These impurities not only easily lead to the degradation of the target DNA, but also directly affect the accuracy of subsequent research. Appropriate methods need to be adopted to remove impurities, protect the integrity of nucleic acids, and ensure the effectiveness of downstream experiments.

[0004] Although there are some fecal nucleic acid extraction reagent methods on the market, such as patent CN 116179540A, a fecal DNA extraction kit and a fecal DNA extraction method, no binding liquid needs to be added during the extraction process, but due to the complex composition of feces, the first, second, and third treatment liquids need to be used in this method to pre-treat the fecal sample to remove organic matter in the fecal sample, but the overall operation is complicated. Although patent CN 116926065B uses mercaptoethanol as a nucleic acid protective agent, mercaptoethanol has a strong pungent odor and is highly irritating to the eyes and skin, which is not conducive to the safety of users. In general, most methods still have the following problems: complex operation, requiring multiple steps and professional skills, not suitable for general laboratory personnel; expensive products or using toxic chemicals, limiting large-scale use; low extraction efficiency, resulting in low quality of extracted nucleic acids, affecting subsequent experimental results; incomplete extraction, easy to be contaminated, affecting the reliability of extraction results; inappropriate specifications, unable to meet the experimental requirements of different specifications, requiring multiple extractions and tests, cross contamination and other problems. Summary of the invention

[0005] In order to solve the problems in the prior art, the present invention provides a stool nucleic acid extraction kit and an extraction method, which achieve the purposes of high extraction quality, simple operation, cheap product, complete extraction, and low pollution.

[0006] The present invention solves the technical problem by adopting the following technical solutions:

[0007] The present invention aims to provide a stool nucleic acid extraction kit, which comprises grinding beads, a cleaning solution, a lysis solution, a binding solution, a magnetic bead suspension, a washing solution and an elution solution.

[0008] Furthermore, the impurity removal liquid includes Al2(SO4)3 with a mass concentration of 5% to 10%, Na4P2O7 with a mass concentration of 2% to 8%, and C4H 10 O alkaline solution.

[0009] Furthermore, the mass concentration of Al2(SO4)3 in the impurity removal solution is 5%, the mass concentration of Na4P2O7 is 3%, and the mass concentration of C4H 10 The mass concentration of O is 1%, and the alkaline solution uses NaOH with a molar concentration of 30 mM.

[0010] Furthermore, the lysis solution includes 0.4M Tris-HCl, 5-10mM heavy metal chelator, 0.5M C6H 15 N5·HCl, 2-4M CH6ClN3, 2-8% by mass concentration of TritonX-100, 2-8% by mass concentration of Tween-20, pH 7.5.

[0011] In the lysis solution system provided by the present invention, 5-10 mM heavy metal chelators can bind to the Ca2+ required by the enzyme. 2+ Mg 2+ The metal ions such as TritonX-100 and Tween-20 can inhibit the activity of nucleases, prevent the released DNA from being decomposed by nucleases, and protect the extracted DNA molecules from degradation. TritonX-100 with a mass percentage concentration of 2-8% and Tween-20 with a mass percentage of 2-8% as surfactants can promote the dissolution of lipids and proteins, promote the full lysis of cells and the precipitation of nucleic acids.

[0012] Furthermore, the metal chelator in the lysis solution uses EDTA-2Na with a molar concentration of 5 mM, CH6ClN3 is 4 M, the mass percentage concentration of TritonX-100 is 5%, and the mass percentage concentration of Tween-20 is 5%.

[0013] Furthermore, the grinding beads are 0.5 mm zirconium oxide grinding beads, and the magnetic bead suspension uses silica surface magnetic beads with a particle size of 100-500 nm and a concentration of 50-100 mg / mL. Preferably, the magnetic beads have a particle size of 300 nm and a concentration of 50 mg / mL.

[0014] Furthermore, the binding solution includes 30 mM Tris-HCl, 3 M CH6ClN3 and a precipitation aid with a mass percentage concentration of 2% to 10%, and the precipitation aid is preferably PEG8000 with a mass percentage concentration of 8%.

[0015] Furthermore, the washing solution includes washing solution 1 and washing solution 2, washing solution 1 includes 20mM Tris-HCl, 1MCH6ClN3, 1M NaCl, 5% Tween-20 and a precipitation aid with a mass percentage concentration of 5% to 15%; the precipitation aid is preferably PEG8000 with a mass percentage concentration of 12%, and washing solution 2 is 10mM Tris-HCl, with 4 times the volume of ethanol solution added, pH 8.0.

[0016] Furthermore, the eluent was 10 mM Tris-HCl, pH 8.0.

[0017] A method for extracting nucleic acid from feces comprises the following steps:

[0018] Take a stool sample, add lysis buffer and grinding beads, mix at full speed to homogenize and break the cell wall, heat and lyse, centrifuge and then aspirate the supernatant A;

[0019] Add impurity removal solution to supernatant A, incubate and centrifuge to obtain supernatant B, add magnetic bead suspension and binding solution to supernatant B to form magnetic bead-DNA complex, wash with washing solution 1 and washing solution 2, and elute with elution solution to obtain fecal DNA.

[0020] Compared with the prior art, the beneficial technical effects of the present invention are:

[0021] 1. The present invention is different from conventional fecal nucleic acid extraction schemes; conventional fecal nucleic acid extraction schemes may precipitate some microorganisms during the impurity removal process, while this scheme first grinds the fecal sample to break the cell wall of the microorganisms and lyse them at the same time; then an original impurity removal solution is used to remove phenols, acids, and polysaccharides in the lysate to obtain a high-purity DNA sample.

[0022] 2. The entire nucleic acid extraction method of the present invention is simple and safe, does not require the preparation of solvents such as isopropanol, and has the effect of high nucleic acid extraction concentration and good integrity. In addition, the binding solution, magnetic bead suspension, washing solution 1, washing solution 2, and eluent of the kit can be pre-packed and used in combination with an automatic nucleic acid extractor. It is simple, convenient, safe, efficient, and has broad application prospects.

[0023] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention, it can be implemented according to the contents of the specification. In order to make the above contents of the present invention and its objectives, features and advantages more obvious and easy to understand, the specific implementation methods of the present invention are listed below. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is a comparison chart of the products extracted from the kits of different manufacturers in Experimental Example 2 of the present invention.

[0025] Figure 2 This is a comparison chart of the electrophoresis results of amplification products of kits from different manufacturers in Experimental Example 3 of the present invention. DETAILED DESCRIPTION

[0026] The technical solution of the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary illustrations and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0027] In addition, unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.

[0028] Example 1

[0029] The impurity removal solution in the kit: the mass concentration of Al2(SO4)3 is 5%, the mass concentration of Na4P2O7 is 2%, and the mass concentration of C4H 10 The mass concentration of O is 0.5%, and the molar concentration of the alkaline solution is 20 mM NaOH.

[0030] Example 2

[0031] The impurity removal solution in the kit: the mass concentration of Al2(SO4)3 is 10%, the mass concentration of Na4P2O7 is 8%, and the mass concentration of C4H 10 The mass concentration of O is 2%, and the molar concentration of the alkaline solution is 40 mM NaOH.

[0032] Example 3

[0033] The impurity removal solution in the kit: the mass concentration of Al2(SO4)3 is 5%, the mass concentration of Na4P2O7 is 3%, and the mass concentration of C4H 10 The mass concentration of O is 1%, and the molar concentration of the alkaline solution is 30 mM NaOH.

[0034] Example 4

[0035] The impurity removal solution in the kit: the mass concentration of Al2(SO4)3 is 5%, the mass concentration of Na4P2O7 is 3%, and the molar concentration of the alkaline solution is 30mM NaOH.

[0036] Example 5

[0037] The impurity removal solution in the kit: the mass concentration of Al2(SO4)3 is 5%, the mass concentration of Na4P2O7 is 3%, and the mass concentration of C4H 10 The mass concentration of O is 1%.

[0038] In the above-mentioned Examples 1-5, the alkaline solution is not stored together with the other components.

[0039] Example 6: Extraction of fecal DNA

[0040] In this embodiment, the stool nucleic acid extraction kit of the present invention is used to extract nucleic acid from the same stool sample. The stool nucleic acid extraction kit uses the impurity removal solutions of Examples 1-5 to extract nucleic acid from the same stool sample, and is used with an automated nucleic acid extractor for automatic extraction. Each impurity removal solution is used to process three groups of stool samples. The specific extraction steps are as follows:

[0041] (1) Take 200-300 mg of fecal sample, add 500 μL of lysis buffer and 0.5 mg of grinding beads, and mix at 2800 rpm for 5 min to homogenize and break the cell wall.

[0042] (2) Heat the cells at 65°C for 10 min, centrifuge and aspirate the supernatant.

[0043] (3) Add 100 μL of decontamination solution to the supernatant, incubate for 2 min, and centrifuge at 8000 rpm for 1 min.

[0044] (4) Pipette 400 μL of the supernatant obtained in step (3) into a 96-well pre-packed reagent plate. For non-pre-packed reagents, add 15 μL of magnetic bead suspension + 300 μL of sterile water to the 1 / 7 column of the 96-well deep-well plate, 500 μL of binding solution to the 2 / 8 column of the 96-well deep-well plate, 600 μL of washing solution 1 to the 3 / 9 column, 600 μL of washing solution 2 to the 4 / 5 / 10 / 11 column, and 100 μL of elution solution to the 6 / 12 column. Place the deep-well plate in the instrument slot, put on the magnetic rod cover, and run the program.

[0045] The above lysis buffer is 0.4M Tris-HCl, 5mM EDTA-2Na, 0.5M C6H 15 N5·HCl, 4M CH6ClN3, 5% TritonX-100 by mass percentage, 5% Tween-20 by mass percentage, pH 7.5; the binding solution is 30mM Tris-HCl, 3M CH6ClN3, and 8% PEG8000 by mass percentage; the washing solution 1 is 20mM Tris-HCl, 1M CH6ClN3, 1M NaCl, 5% Tween-20, and 12% PEG8000 by mass percentage; the washing solution 2 is 10mM Tris-HCl, with 4 times the volume of ethanol solution added, pH 8.0; the elution solution is 10mM Tris-HCl, pH 8.0, the grinding beads are 0.5mm zirconium oxide grinding beads, and the magnetic bead suspension is silica surface magnetic beads with a particle size of 300nm and a concentration of 50mg / mL.

[0046] After the automated program is finished, transfer the eluate from column 6 / 12 to a new centrifuge tube and use Nanodrop One to detect the concentration and purity of the extracted product:

[0047] A260nm: It is the absorption wavelength of the highest absorption peak of nucleic acid, A280nm: It is the highest absorption wavelength of protein, and the ratio can be used to evaluate the purity of nucleic acid samples. The A260 / A280 ratio of purer DNA should be greater than 1.8. If the ratio is low, it indicates that there is contamination by protein or phenolic substances, and the sample needs to be purified. A230nm: It is the absorption wavelength of the highest absorption peak of carbohydrates, and the ratio can be used to evaluate the purity of nucleic acid samples: The 260 / A230 ratio of purer DNA is generally between 1.8 and 2.2; if the ratio is less than 1.8, it indicates that the sample is contaminated by carbohydrates (sugars), salts or organic solvents, and if the ratio is less than 1.5, it means that there may be phenolic residues in the sample.

[0048] Table 1 Comparison of DNA concentration and purity in different formulas of impurity removal solutions

[0049]

[0050] As can be seen from Table 1, the five impurity removal solutions can remove impurities in feces to a certain extent, but there are obvious differences in the concentration and purity of the DNA extracted after impurity removal. The DNA purity extracted from the feces sample treated with the impurity removal solution in Example 2 is higher, but the DNA concentration extracted from the feces sample treated with the impurity removal solution in Example 3 is higher than that in Example 2. It can be seen that Al2(SO4)3, Na4P2O7, C4H 10 O will also adsorb a certain amount of nucleic acid when adsorbing impurities. It can be seen that the impurity removal liquid ratio provided by the present invention can reduce the adsorption of DNA.

[0051] Experimental Example 1: Comparison of the concentration and purity of the extracted products from different stool nucleic acid extraction kits

[0052] This test example compares the DNA extraction effect of the stool nucleic acid extraction kit provided by the present invention with that of two commercially available nucleic acid extraction kits, as follows:

[0053] Fecal Nucleic Acid Extraction Kit 1: Manufacturer A, the binding solution in this kit is isopropanol, and there is no impurity removal solution;

[0054] Fecal nucleic acid extraction kit 2: The nucleic acid extraction kit of the present invention comprises grinding beads, lysis solution, impurity removal solution, binding solution, alkaline solution, magnetic bead suspension, washing solution 1, washing solution 2 and elution solution.

[0055] The lysis buffer was 0.4M Tris-HCl, 5mM EDTA-2Na, 0.5M C6H 15 N5·HCl, 4M CH6ClN3, 5% TritonX-100, 5% Tween-20, pH 7.5;

[0056] The mass concentration of Al2(SO4)3 in the impurity removal solution is 5%, the mass concentration of Na4P2O7 is 3%, and the mass concentration of C4H 10 The mass concentration of O is 1%, and the alkaline solution is NaOH with a molar concentration of 30 mM;

[0057] The binding solution is 30mM Tris-HCl, 3M CH6ClN3, and PEG8000 with a mass percentage concentration of 8%;

[0058] Washing solution 1 is 20 mM Tris-HCl, 1 M CH6ClN3, 1 M NaCl, 5% Tween-20, and 12% PEG8000 by mass percentage;

[0059] Washing solution 2 was 10 mM Tris-HCl, with 4 volumes of ethanol solution added, pH 8.0; the elution solution was 10 mM Tris-HCl, pH 8.0.

[0060] The grinding beads are 0.5 mm zirconium oxide grinding beads, and the magnetic bead suspension is silica surface magnetic beads with a particle size of 300 nm and a concentration of 50 mg / mL.

[0061] Fecal Nucleic Acid Extraction Kit 3: Manufacturer B, this kit is to remove impurities first and then lyse and combine.

[0062] Fecal nucleic acid extraction: The extraction method of fecal nucleic acid extraction kit 2 is the same as that of Example 6, and the fecal nucleic acid extraction kits 1 and 3 are used for extraction according to the corresponding instructions.

[0063] Table 2 Comparison of concentration and purity of extraction products from different fecal nucleic acid extraction kits

[0064]

[0065] It can be seen from Table 2 that although the concentration of the extracted product of the kit of manufacturer A is relatively high, no impurity removal operation is performed, and the product A260 / A230 ratio is much less than 1.8, indicating that there are more carbohydrates (sugars), salts or organic solvents in the product; the A260 / A280 and A260 / A230 of the extracted product of the kit of manufacturer B show good impurity removal effect, but the nucleic acid yield is low; the nucleic acid extraction kit of the present invention performs better in terms of yield and purity.

[0066] Test Example 2: Comparison of Background Bacteria Removal Effects of Different Fecal Nucleic Acid Extraction Kits

[0067] This test example compares the DNA extraction effect of the stool nucleic acid extraction kit provided by the present invention with that of two commercially available nucleic acid extraction kits, as follows:

[0068] Fecal Nucleic Acid Extraction Kit 1: Manufacturer A, the binding solution in this kit is isopropanol, and there is no impurity removal solution;

[0069] Fecal nucleic acid extraction kit 2: The nucleic acid extraction kit of the present invention includes grinding beads, lysis solution, impurity removal solution, binding solution, alkaline solution, magnetic bead suspension, washing solution 1, washing solution 2 and elution solution, and the specific proportion is the same as that of kit 2 in test example 1.

[0070] Fecal Nucleic Acid Extraction Kit 3: Manufacturer B, this kit is to remove impurities first and then lyse and combine.

[0071] Fecal nucleic acid extraction: The extraction method of fecal nucleic acid extraction kit 2 is the same as that of Example 6, and the fecal nucleic acid extraction kits 1 and 3 are used for extraction according to the corresponding instructions.

[0072] The results of fecal nucleic acid extraction using the above three kits are as follows Figure 1 As shown: 1-3 are the extraction products of the kit of manufacturer A, 4-6 are the extraction products of the present invention, and 7-9 are the extraction products of the kit of manufacturer B.

[0073] Depend on Figure 1 It can be seen that the DNA extracted by the present invention has a higher content and better integrity, and can effectively remove background DNA.

[0074] Experimental Example 3: Comparison of PCR amplification of products extracted from different stool nucleic acid extraction kits

[0075] Fecal Nucleic Acid Extraction Kit 1: Manufacturer B, this kit is to remove impurities first and then lyse and combine;

[0076] Fecal nucleic acid extraction kit 2: The fecal nucleic acid extraction kit of the present invention has the same specific proportions as kit 2 in Experimental Example 1.

[0077] The extracted product was used as a template to perform PCR amplification on microbial 16S. The program was 95°C, 30S; 95°C, 5S, 60°C, 20S, 34 cycles. The reaction system was as follows:

[0078]

[0079] The amplified product was subjected to agarose gel electrophoresis. Figure 2 , where the concentration of agarose gel is 2%.

[0080] like Figure 2 As shown: 10-12 are the amplified products after extraction with the kit of manufacturer B, and 13-15 are the amplified products after extraction with the present invention. Figure 2 It can be seen that the use of the impurity remover of the present invention has a better effect in removing PCR inhibitors.

[0081] The serial numbers of the above embodiments of the present invention are only for description and do not represent the advantages or disadvantages of the embodiments.

[0082] The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementation modes, which are merely illustrative rather than restrictive. Under the guidance of the present invention, ordinary technicians in this field can also make many forms without departing from the scope of protection of the present invention and the claims, all of which are within the protection of the present invention.

Claims

1. A stool nucleic acid extraction kit, characterized in that: It includes grinding beads, impurity removal solution, lysis solution, binding solution, magnetic bead suspension, washing solution and elution solution.

2. A stool nucleic acid extraction kit according to claim 1, characterized in that: The impurity removal liquid includes Al2(SO4)3 with a mass concentration of 5% to 10%, Na4P2O7 with a mass concentration of 2% to 8%, and C4H 10 O alkaline solution.

3. A stool nucleic acid extraction kit according to claim 2, characterized in that: The mass concentration of Al2(SO4)3 in the impurity removal solution is 5%, the mass concentration of Na4P2O7 is 3%, and the mass concentration of C4H 10 The mass concentration of O is 1%, and the alkaline solution uses NaOH with a molar concentration of 30 mM.

4. A stool nucleic acid extraction kit according to claim 1, characterized in that: The lysis buffer includes 0.4M Tris-HCl, 5-10mM heavy metal chelating agent, 0.5M C6H 15 N5·HCl, 2-4M CH6ClN3, 2-8% by mass concentration of TritonX-100, 2-8% by mass concentration of Tween-20, pH 7.

5.

5. A stool nucleic acid extraction kit according to claim 4, characterized in that: The metal chelating agent in the lysis solution is EDTA-2Na with a molar concentration of 5 mM, CH6ClN3 is 4 M, the mass percentage concentration of TritonX-100 is 5%, and the mass percentage concentration of Tween-20 is 5%.

6. A stool nucleic acid extraction kit according to claim 1, characterized in that: The grinding beads are 0.5 mm zirconium oxide grinding beads, and the magnetic bead suspension uses silica surface magnetic beads with a particle size of 100 to 500 nm and a concentration of 50 to 100 mg / mL.

7. A stool nucleic acid extraction kit according to claim 1, characterized in that: The binding solution includes 30mM Tris-HCl, 3M CH6ClN3 and a precipitation aid with a mass percentage concentration of 2% to 10%.

8. A stool nucleic acid extraction kit according to claim 1, characterized in that: The washing solution includes washing solution 1 and washing solution 2. Washing solution 1 includes 20mM Tris-HCl, 1M CH6ClN3, 1M NaCl, 5% Tween-20 and a precipitation aid with a mass percentage concentration of 5% to 15%; washing solution 2 is 10mM Tris-HCl, added with 4 times the volume of ethanol solution, pH 8.

0.

9. A stool nucleic acid extraction kit according to claim 1, characterized in that: The eluent was 10 mM Tris-HCl, pH 8.

0.

10. The method for extracting nucleic acid from stool according to any one of claims 1 to 9, characterized in that: The following steps are involved: Take a stool sample, add lysis buffer and grinding beads, mix at full speed to homogenize and break the cell wall, heat and lyse, centrifuge and aspirate the supernatant A; Add impurity removal solution to supernatant A, incubate and centrifuge to obtain supernatant B, add magnetic bead suspension and binding solution to supernatant B to form magnetic bead-DNA complex, wash with washing solution, and elute with elution solution to obtain fecal DNA.

Citation Information

Cited By

  • Feces human DNA high-purity extraction method based on secondary magnetic bead purification

    CN122279002A